These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36757398)

  • 1. Lipid metabolism and the targeting of angiopoietin-like 3: Experimental drugs under development.
    Polychronopoulos G; Kostourou DT; Tziomalos K
    Expert Opin Investig Drugs; 2023 Mar; 32(3):177-180. PubMed ID: 36757398
    [No Abstract]   [Full Text] [Related]  

  • 2. ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets.
    Akoumianakis I; Zvintzou E; Kypreos K; Filippatos TD
    Curr Atheroscler Rep; 2021 Mar; 23(5):20. PubMed ID: 33694000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evinacumab to treat hypercholesterolemia.
    Engler C; Ebenbichler C
    Drugs Today (Barc); 2021 Oct; 57(10):607-619. PubMed ID: 34713869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.
    Dewey FE; Gusarova V; Dunbar RL; O'Dushlaine C; Schurmann C; Gottesman O; McCarthy S; Van Hout CV; Bruse S; Dansky HM; Leader JB; Murray MF; Ritchie MD; Kirchner HL; Habegger L; Lopez A; Penn J; Zhao A; Shao W; Stahl N; Murphy AJ; Hamon S; Bouzelmat A; Zhang R; Shumel B; Pordy R; Gipe D; Herman GA; Sheu WHH; Lee IT; Liang KW; Guo X; Rotter JI; Chen YI; Kraus WE; Shah SH; Damrauer S; Small A; Rader DJ; Wulff AB; Nordestgaard BG; Tybjærg-Hansen A; van den Hoek AM; Princen HMG; Ledbetter DH; Carey DJ; Overton JD; Reid JG; Sasiela WJ; Banerjee P; Shuldiner AR; Borecki IB; Teslovich TM; Yancopoulos GD; Mellis SJ; Gromada J; Baras A
    N Engl J Med; 2017 Jul; 377(3):211-221. PubMed ID: 28538136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evinacumab for the treatment of homozygous familial hypercholesterolemia.
    Gao Y; Zhang B; Yang J
    Expert Rev Clin Pharmacol; 2022 Feb; 15(2):139-145. PubMed ID: 35220876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietin-like 3 inhibition and the liver: less is more?
    Oostveen RF; Hovingh GK; Stroes ESG
    Curr Opin Lipidol; 2023 Dec; 34(6):267-271. PubMed ID: 37820081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will evinacumab become the standard treatment for homozygous familial hypercholesterolemia?
    Doggrell SA
    Expert Opin Biol Ther; 2021 Mar; 21(3):299-302. PubMed ID: 33295805
    [No Abstract]   [Full Text] [Related]  

  • 8. Evinacumab: a new option in the treatment of homozygous familial hypercholesterolemia.
    Pirillo A; Catapano AL
    Expert Opin Biol Ther; 2022 Jul; 22(7):813-820. PubMed ID: 35698895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evinacumab for Homozygous Familial Hypercholesterolemia.
    Raal FJ; Rosenson RS; Reeskamp LF; Hovingh GK; Kastelein JJP; Rubba P; Ali S; Banerjee P; Chan KC; Gipe DA; Khilla N; Pordy R; Weinreich DM; Yancopoulos GD; Zhang Y; Gaudet D;
    N Engl J Med; 2020 Aug; 383(8):711-720. PubMed ID: 32813947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learned from the evinacumab trials in the treatment of homozygous familial hypercholesterolemia.
    Khoury E; Croteau L; Lauzière A; Gaudet D
    Future Cardiol; 2022 Jun; 18(6):507-518. PubMed ID: 35469449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiopoietin-like proteins as therapeutic targets for cardiovascular disease: focus on lipid disorders.
    Morelli MB; Chavez C; Santulli G
    Expert Opin Ther Targets; 2020 Jan; 24(1):79-88. PubMed ID: 31856617
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia.
    Ahmad Z; Banerjee P; Hamon S; Chan KC; Bouzelmat A; Sasiela WJ; Pordy R; Mellis S; Dansky H; Gipe DA; Dunbar RL
    Circulation; 2019 Aug; 140(6):470-486. PubMed ID: 31242752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evinacumab for treatment of familial hypercholesterolemia.
    Warden BA; Duell PB
    Expert Rev Cardiovasc Ther; 2021 Aug; 19(8):739-751. PubMed ID: 34253139
    [No Abstract]   [Full Text] [Related]  

  • 14. Evinacumab in Patients with Refractory Hypercholesterolemia.
    Rosenson RS; Burgess LJ; Ebenbichler CF; Baum SJ; Stroes ESG; Ali S; Khilla N; Hamlin R; Pordy R; Dong Y; Son V; Gaudet D
    N Engl J Med; 2020 Dec; 383(24):2307-2319. PubMed ID: 33196153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects.
    Harada-Shiba M; Ali S; Gipe DA; Gasparino E; Son V; Zhang Y; Pordy R; Catapano AL
    Atherosclerosis; 2020 Dec; 314():33-40. PubMed ID: 33130482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits.
    Mehta N; Qamar A; Qu L; Qasim AN; Mehta NN; Reilly MP; Rader DJ
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1057-63. PubMed ID: 24626437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopoietin-3, a novel member of the angiopoietin family.
    Nishimura M; Miki T; Yashima R; Yokoi N; Yano H; Sato Y; Seino S
    FEBS Lett; 1999 Apr; 448(2-3):254-6. PubMed ID: 10218486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity.
    Banerjee P; Chan KC; Tarabocchia M; Benito-Vicente A; Alves AC; Uribe KB; Bourbon M; Skiba PJ; Pordy R; Gipe DA; Gaudet D; Martin C
    Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2248-2260. PubMed ID: 31578082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics and exposure-response modeling for evinacumab in homozygous familial hypercholesterolemia.
    Pu X; Sale M; Yang F; Zhang Y; Davis JD; Al-Huniti N
    CPT Pharmacometrics Syst Pharmacol; 2021 Nov; 10(11):1412-1421. PubMed ID: 34585515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting angiopoietin-like 3 in atherosclerosis: From bench to bedside.
    Ling P; Zheng X; Luo S; Ge J; Xu S; Weng J
    Diabetes Obes Metab; 2021 Sep; 23(9):2020-2034. PubMed ID: 34047441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.